Company news
Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG) news
Every Hemab Therapeutics Holdings, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the IST...
July 14, 2026
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding ...
July 12, 2026
Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Hemab Therapeutics Reports First Quarter 2026 Financial Results
May 21, 2026
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ...
May 4, 2026
Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering
April 30, 2026